$6.40
-0.12-1.84%
Last update: 8:09 AM
15 minutes delayed
Comments
Loading...
Syros Pharmaceuticals
SYRSNASDAQ
Syros Pharmaceuticals (NASDAQ:SYRS) Stock, Earnings Estimates, EPS, And Revenue
Syros Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 6
EPS Estimate
$-0.770
Quarterly Revenue Estimate
$460K
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$7M
Analyze the earnings history of Syros Pharmaceuticals using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SYRS | Syros Pharmaceuticals | -$1.30 | -$0.77 | — | — | $2.83M | $460.00K | — | — | 08/06/2024 | Get Alert |
| SYRS | Syros Pharmaceuticals | -$0.85 | -$0.87 | -$0.10 | 88.51% | $2.95M | $720.00K | $0.00 | -100.00% | 05/14/2024 | Get Alert |
| SYRS | Syros Pharmaceuticals | -$0.17 | -$1.14 | -$2.18 | -91.23% | -$754.00K | $2.00M | $387.00K | -80.65% | 03/27/2024 | Get Alert |
| SYRS | Syros Pharmaceuticals | -$3.21 | -$1.14 | -$1.43 | -25.44% | $3.89M | $3.94M | $3.76M | -4.52% | 11/14/2023 | Get Alert |
| SYRS | Syros Pharmaceuticals | -$5.40 | -$1.13 | -$1.30 | — | $6.28M | $3.50M | $2.83M | -19.14% | 08/08/2023 | Get Alert |
| SYRS | Syros Pharmaceuticals | -$3.99 | -$1.09 | -$0.85 | 22.02% | $5.47M | $3.26M | $2.95M | -9.39% | 05/10/2023 | Get Alert |
| SYRS | Syros Pharmaceuticals | -$3.80 | -$1.35 | -$0.17 | 87.41% | $7.80M | — | -$754.00K | — | 03/02/2023 | Get Alert |
| SYRS | Syros Pharmaceuticals | -$4.10 | -$4.01 | -$3.21 | 19.95% | $5.70M | $5.22M | $3.89M | -25.46% | 11/14/2022 | Get Alert |
| SYRS | Syros Pharmaceuticals | -$3.60 | -$3.50 | -$5.40 | -54.29% | $5.16M | $4.57M | $6.28M | 37.33% | 08/09/2022 | Get Alert |
| SYRS | Syros Pharmaceuticals | -$2.30 | -$4.70 | -$4.00 | 14.89% | $4.83M | $4.92M | $5.47M | 11.12% | 05/16/2022 | Get Alert |
| SYRS | Syros Pharmaceuticals | -$6.20 | -$4.70 | -$3.80 | 19.15% | $5.70M | $4.80M | $7.80M | 62.54% | 03/15/2022 | Get Alert |
| SYRS | Syros Pharmaceuticals | -$4.30 | -$4.40 | -$4.10 | 6.82% | $3.83M | $4.49M | $5.70M | 26.88% | 11/05/2021 | Get Alert |
| SYRS | Syros Pharmaceuticals | -$3.80 | -$3.70 | -$3.60 | 2.70% | $3.19M | $4.13M | $5.16M | 24.99% | 08/05/2021 | Get Alert |
| SYRS | Syros Pharmaceuticals | -$3.90 | -$4.60 | -$2.30 | 50.00% | $2.38M | $2.67M | $4.83M | 80.79% | 05/06/2021 | Get Alert |
| SYRS | Syros Pharmaceuticals | -$4.60 | -$5.00 | -$6.20 | -24.00% | $508.00K | $2.70M | $5.70M | 111.04% | 03/04/2021 | Get Alert |
| SYRS | Syros Pharmaceuticals | -$4.70 | -$3.80 | -$4.30 | -13.16% | $558.00K | $2.54M | $3.83M | 50.71% | 11/05/2020 | Get Alert |
| SYRS | Syros Pharmaceuticals | -$4.70 | -$4.00 | -$3.80 | 5.00% | $462.00K | $1.90M | $3.19M | 67.79% | 08/06/2020 | Get Alert |
| SYRS | Syros Pharmaceuticals | -$4.90 | -$4.30 | -$3.90 | 9.30% | $454.00K | $1.62M | $2.38M | 46.85% | 05/07/2020 | Get Alert |
| SYRS | Syros Pharmaceuticals | -$5.40 | -$4.70 | -$4.60 | 2.13% | $893.00K | $690.00K | $508.00K | -26.38% | 03/05/2020 | Get Alert |
| SYRS | Syros Pharmaceuticals | -$4.70 | -$4.80 | -$4.70 | 2.08% | $412.00K | $440.00K | $558.00K | 26.82% | 11/12/2019 | Get Alert |
| SYRS | Syros Pharmaceuticals | -$4.30 | -$4.20 | -$4.70 | -11.90% | $375.00K | $430.00K | $462.00K | 7.44% | 08/01/2019 | Get Alert |
Syros Pharmaceuticals (SYRS) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-14 | $-0.10 | $-0.87 | 88.5 % |
| Dec 2023 | 2024-03-27 | $-2.18 | $-1.14 | -91.2 % |
| Sep 2023 | 2023-11-14 | $-1.43 | $-1.14 | -25.4 % |
| Mar 2023 | 2023-05-10 | $-0.85 | $-1.09 | 22.0 % |
Syros Pharmaceuticals (SYRS) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-14 | $0 | $720.00K | -100.0 % |
| Dec 2023 | 2024-03-27 | $387.00K | $2.00M | -80.7 % |
| Sep 2023 | 2023-11-14 | $3.76M | $3.94M | -4.52 % |
| Jun 2023 | 2023-08-08 | $2.83M | $3.50M | -19.1 % |
FAQ
When is Syros Pharmaceuticals (NASDAQ:SYRS) reporting earnings?
Syros Pharmaceuticals (SYRS) is scheduled to report earnings on August 6, 2024. The last reported earnings were for reported on May 14, 2024 for Q1.
What were the latest earnings per share (EPS) for Syros Pharmaceuticals (NASDAQ:SYRS)?
The Actual EPS was $-0.10, which beat the estimate of $-0.87.
What were Syros Pharmaceuticals’s (NASDAQ:SYRS) revenues?
The Actual Revenue was $0K, which missed the estimate of $720K.
Browse earnings estimates, EPS, and revenue on all stocks.